Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices

Brain Res. 1998 Mar 23;787(2):348-50. doi: 10.1016/s0006-8993(98)00031-6.

Abstract

The synthesis of kynurenic acid (KYNA) from kynurenine was measured in the cerebral cortical slices. In vitro, ammonium acetate at the subtoxic to toxic concentration range from 1 mM to 10 mM dose-dependently inhibited KYNA synthesis (IC50=2.99 mM). Ammonia treatment in vivo decreased KYNA synthesis by 30%. These results suggest that impaired neuroprotection exerted by KYNA might be a potential contributor to the glutamate receptor-mediated aspect of acute ammonia neurotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / pharmacology*
  • Animals
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism*
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Antagonists / metabolism*
  • In Vitro Techniques
  • Kynurenic Acid / metabolism*
  • Male
  • Neuroprotective Agents / metabolism*
  • Rats
  • Rats, Wistar

Substances

  • Acetates
  • Excitatory Amino Acid Antagonists
  • Neuroprotective Agents
  • Kynurenic Acid
  • ammonium acetate